TPCW
INSM icon

TD Private Client Wealth’s Insmed INSM Stock Holding History

TD Private Client Wealth’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.1K Buy
517
+397
+331% +$48.1K ﹤0.01% 871
2026
Q1 		$19.6K Buy
120
+34
+40% +$5.23K ﹤0.01% 1011
2025
Q4 		$15K Buy
86
+56
+187% +$10.2K ﹤0.01% 1048
2025
Q3 		$4.32K Hold
30
– – ﹤0.01% 1153
2025
Q2 		$3.02K Buy
30
+5
+20% +$382 ﹤0.01% 1172
2025
Q1 		$1.91K Buy
+25
New +$1.91K ﹤0.01% 1198

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

TD Private Client Wealth's INSM Position: Q2 2026 in Review

TD Private Client Wealth increased its Insmed (INSM) stake by 331% in Q2 2026, buying an estimated $48.1K and bringing the position to 517 shares worth $55.1K. The position accounts for ﹤0.01% of the portfolio, ranked #871.

TD Private Client Wealth first reported a position in INSM in Q1 2025 and has held it in 6 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • TD Private Client Wealth held 517 shares of Insmed worth $55.1K as of Q2 2026.
  • TD Private Client Wealth bought 397 Insmed shares in Q2 2026, an estimated $48.1K.
  • Insmed made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #871 holding.
  • TD Private Client Wealth first reported a position in Insmed in Q1 2025 and has held it in 6 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.